Synthetic methodology for the preparation of N-hydroxysulfamides
- PMID: 18437247
- PMCID: PMC2330331
- DOI: 10.1016/j.tetlet.2007.09.037
Synthetic methodology for the preparation of N-hydroxysulfamides
Abstract
A convenient synthesis of a variety of substituted N-hydroxysulfamides from chlorosulfonyl isocyanate is reported. Alkyl groups can be introduced selectively on the N-Boc nitrogen of key intermediates 1a or 1b using the Mitsunobu reaction with alcohols. Subsequently the nitrogen carrying the silyloxy group can be alkylated under traditional conditions. Deprotection to the desired N-hydroxysulfamide can be achieved in high yields. Using this method, a number of structurally diverse N-hydroxysulfamides have been prepared. The usefulness of this methodology has further been demonstrated by the synthesis of more complex targets such as bis-hydroxysulfamide, 5, and cyclic hydroxysulfamides 7 and 8.
References
-
- Lori F, Kelly LM, Foli A, Lisziewicz J. Expert Opinion of Drug Safety. 2004;3(4):279. - PubMed
- Huang J, Zou Z, Kim-Shapiro DB, Ballas SK, King SB. J. Med. Chem. 2003;46:3748. - PubMed
- King SB. Curr. Med. Chem. 2003;10:437. - PubMed
- Granik VG, Grigor'ev NB. Russ. Chem. Bull. Int. Ed. 2002;51:1375.
- Paz-Ares L, Donehower RC. In: Cancer Chemotherapy and Biotherapy-Principles and Practice, ch. 11. 3rd edn. Chabner BA, Longo DL, editors. Philadelphia: Lippincott, Williams, and Wilkins; 2001. pp. 315–328.
- Frank I. J. Biol. Regulators and Homeostatic Agents. 1999;13(3):186. - PubMed
- Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP. Medicine. 1996;75:300. - PubMed
-
- Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT. Bioorg. Med. Chem. 2007;15:2298. - PubMed
- Wilkins PC, Jacobs HK, Johnson MD, Gopalan AS. Inorg. Chem. 2004;43(24):7877–7881. - PubMed
- Lee MJC, Shoeman DW, Goon DJW, Nagasawa HT. Nitric Oxide: Biology and Chemistry. 2001;5:278. - PubMed
- Scozzafava A, Supuran CT. J. Med. Chem. 2000;43:3677. - PubMed
- Mincione F, Menabuoni L, Briganti F, Mincione G, Scozzafava A, Supuran CT. J. Enzyme Inhib. 1998;13:267. - PubMed
-
- Winum J-Y, Scozzafava A, Montero J-L, Supuran CT. Med. Res. Rev. 2006;26:767. - PubMed
- Winum J-Y, Scozzafava A, Montero J-L, Supuran CT. Expert Opinion on Therapeutic Patents. 2006;16(1):27. - PubMed
- Casini A, Winum J-Y, Montero J-L, Scozzafava A, Supuran CT. Bioorg. Med. Chem. Lett. 2003;13:837. - PubMed
- Park JD, Kim DH, Kim S-J, Woo J-R, Ryu SE. J. Med. Chem. 2002;45:5295. - PubMed
- Tozer MJ, Buck IM, Cooke T, Kalindjian SB, McDonald JM, Pether MJ, Steel KIM. Bioorg. Med. Chem. Lett. 1999;9:3103. - PubMed
-
- Winum J-Y, Innocenti A, Nasr J, Montero J-L, Scozzafava A, Vullo D, Supuran CT. Bioorg. Med. Chem. Lett. 2005;15:2353. - PubMed
-
-
For some recent reviews on design of carbonic anhydrase inhibitors see: Winum J-Y, Scozzafava A, Montero J-L, Supuran CT. Curr. Topics Med. Chem. 2007;7:835.Supuran CT, Vullo D, Manole G, Casini A, Scozzafava A. Curr. Med. Chem. Cardiovascular and Hematological Agents. 2004;2:49.Supuran CT, Scozzafava A, Casini A. Med. Res. Rev. 2003;23:146.
-
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous